Who benefits from surveillance imaging?

Journal of Clinical Oncology

Volumn 30, Issue 21, 2012, Pages 2579-2580

  Armitage, James O ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL LYMPHOMA; CANCER RECURRENCE; CANCER REGRESSION; CANCER RELAPSE; CANCER SCREENING; CLINICAL PRACTICE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DISEASE SURVEILLANCE; EDITORIAL; FOLLICULAR LYMPHOMA; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; LARGE CELL LYMPHOMA; LYMPHOMA; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; SALVAGE THERAPY; SENSITIVITY AND SPECIFICITY;

FEMALE; HODGKIN DISEASE; HUMANS; MALE; POPULATION SURVEILLANCE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84864037494     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.42.6189     Document Type: Editorial

References (13)

1. Voss SD, Chen L, Constine LS, et al: Surveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin's lymphoma: A report from the Children's Oncology Group. J Clin Oncol 30:2635-2640, 2012
2. Radford JA, Eardley A, Woodman C, et al: Follow up policy after treatment for Hodgkin's disease: Too many clinic visits and routine tests? A review of hospital records. BMJ 314:343-346, 1997 (Pubitemid 27056556)
3. Wagner-Johnston ND, Bartlett NL: Role of routine imaging in lymphoma. J Natl Compr Canc Netw 9:575-584, 2011; quiz 585
4. Liedtke M, Hamlin PA, Moskowitz CH, et al: Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: A retrospective analysis of a uniformly-treated patient population. Ann Oncol 17:909-913, 2006 (Pubitemid 43778979)
5. Gerlinger M, Rohatiner AZ, Matthews J, et al: Surveillance investigations after high-dose therapy with stem cell rescue for recurrent follicular lymphoma have no impact on management. Haematologica 95:1130-1135, 2010
6. El-Galaly TC, Hutchings M, Bukh A, et al: PET/CT surveillance in patients with Hodgkin lymphoma in first remission. Ann Oncol 22:160, 2011 (suppl 4; abstr 228)
7. Lambert JR, Bomanji JB, Peggs KS, et al: Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphoma. Blood 115:2763-2768, 2010
8. Berrington de González A, Mahesh M, Kim KP, et al: Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med 169:2071-2077, 2009
9. Smith-Bindman R, Lipson J, Marcus R, et al: Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 169:2078-2086, 2009
10. Shenoy P, Sinha R, Tumeh JW, et al: Surveillance computed tomography scans for patients with lymphoma: Is the risk worth the benefits? Clin Lymphoma Myeloma Leuk 10:270-277, 2010
11. Thompson CA, Charlson ME, Schenkein E, et al: Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors. Ann Oncol 21:2262-2266, 2010
12. Petrausch U, Samaras P, Haile SR, et al: Risk-adapted FDG-PET/CT-based follow-up in patients with diffuse large B-cell lymphoma after first-line therapy. Ann Oncol 21:1694-1698, 2010
13. Petrausch U, Samaras P, Veit-Haibach P, et al: Hodgkin's lymphoma in remission after first-line therapy: Which patients need FDG-PET/CT for follow-up? Ann Oncol 21:1053-1057, 2010